June 13, 2025 Weight Loss Drugs Show Promise for Heart Failure ACC statement highlights semaglutide and tirzepatide as therapies associated with improved symptoms and functional capacity in patients with heart failure with preserved ejection fraction and obesity. Conexiant
June 12, 2025 Resectable NSCLC: Overall Survival With Neoadjuvant Nivolumab Plus Chemotherapy The ASCO Post
June 10, 2025 Study Shows Potential Benefits of AI-Assisted Classification in HER2-Low and HER2-Ultralow Breast Cancer The ASCO Post
June 10, 2025 Structured Exercise Program Improves Survival Outcomes in Patients With Stage III or High-Risk Stage II Colon Cancer The ASCO Post
June 11, 2025 Evolving Role of Surgical De-escalation for Endometrial, Ovarian, Cervical, and Vulvar Cancers The ASCO Post
May 22, 2025 Quick Takes on Research Findings on Novel Therapies for Gynecologic Cancers The ASCO Post
May 22, 2025 Combination Therapy for Newly Diagnosed, BRCA-Nonmutated, Advanced Epithelial Ovarian Cancer The ASCO Post
June 12, 2025 Navigating the Rapid Evolution of Dry Eye Treatment in Private Practice The Ophthalmologist
June 10, 2025 Why Most Instrument Startups Fail – and What to Do Differently The Analytical Scientist